PMID: 11917814Mar 29, 2002Paper

Nontuberculous mycobacteria in cystic fibrosis

Infectious Disease Clinics of North America
Deborah L Ebert, Kenneth Olivier

Abstract

The incidence of NTM pulmonary infections increasingly is recognized in patients with CF. This may reflect the increasing longevity of this population with increased environmental exposure time, a high index of suspicion, and/or some as of yet unidentified predisposing factor(s). The most common species of NTM in CF is MAC, followed by M. abscessus. The authors recommend that adult patients with CF be screened for the presence of NTM pulmonary secretions on a regular basis. Positive cultures are likely to indicate disease if they are multiple or if a patient has clinical evidence of pulmonary disease exacerbation (increased cough, increased purulence of secretions, or systemic manifestations such as fever and weight loss) that is not responding to conventional antibiotic therapy. CF patients who do not respond to treatment for the usual organisms should be re-evaluated for the presence of NTM and treated with a macrolide-containing regimen directed against the identified NTM if diagnostic criteria are met. Novel treatments with cytokines and intermittent dosing of antibiotics are currently under investigation.

References

May 1, 1992·The American Review of Respiratory Disease·R E HuebnerR J O'Brien
Dec 1, 1982·The Journal of Infectious Diseases·R C Good, D E Snider
Apr 1, 1980·The Journal of Pediatrics·B Boxerbaum
Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·P A FlumeJ R Yankaskas
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·G ChatteY Pacheco
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·K HjeltC Koch
Jul 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C F von ReynT W Barber
Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·T P Kennedy, D J Weber
May 1, 1994·American Journal of Respiratory and Critical Care Medicine·R J WallaceG H Mazurek
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·R J WallaceD T Murphy
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·J F TomashefskiC F Doershuk
Dec 26, 1996·The New England Journal of Medicine·M J NewportM Levin
Feb 1, 1997·The Pediatric Infectious Disease Journal·C M OermannD K Seilheimer
Apr 1, 1997·The Pediatric Infectious Disease Journal·B FaurouxH Vu Thien
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J E FergieW W Stafford
Jun 1, 1997·American Journal of Respiratory and Critical Care Medicine·E TanakaF Kuze
Jul 11, 1998·Thorax·J K TorrensE Moya
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L BurnsC R Clausen
Sep 2, 1998·The Annals of Thoracic Surgery·K G NelsonR J Wallace
Mar 20, 1999·Chest·S Kesten, C Chaparro
Oct 9, 1999·The European Respiratory Journal·M GilljamL O Larsson
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·M A Malouf, A R Glanville
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E GriffithR J Wallace
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·A R CullenA A Colin

❮ Previous
Next ❯

Citations

Nov 25, 2004·Antimicrobial Agents and Chemotherapy·George CarterLuiz E Bermudez
Oct 16, 2009·Pediatric Pulmonology·Dhenuka K RadhakrishnanSharon D Dell
May 27, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Björn Petrini
Feb 22, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Maarten VerregghenCornelis K van der Ent
Nov 27, 2010·Paediatric Respiratory Reviews·A M M de VrankrijkerC K van der Ent
Nov 29, 2011·Revista clínica española·E Martínez-CerónR Álvarez-Sala
Oct 10, 2002·Clinics in Chest Medicine·Charles L Daley, David E Griffith
Aug 2, 2005·Diagnostic Microbiology and Infectious Disease·Marlene T DytocRobert P Rennie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.